“A solid growth play is a name that appears poised to not only grow at an above-average rate but also reward investors handsomely over the long run,” notes the author of today’s article, who proceeds to highlight three “Buy-rated stocks flagged by the analysts for their strong long-term growth narratives. On top of this, each boasts substantial upside potential from the current share price.” For these three stocks – including a biopharmaceutical company focused on underserved patient communities – For more, CLICK HERE.
Assessing the current landscape for stocks, the author of today’s article notes that “First, almost nobody across Wall Street thinks we will have a recession in 2019.” He also notes that, while earnings are likely to be lower in 2019 than they were in 2018, there will still be upside – and the Fed could very well not raise interest rates at all. With this in mind, he proceeds to highlight six Buy-rated stocks with solid dividends (and the best volatility ratings) to consider buying this year. For more, CLICK HERE.